Product identification
This is a two-component peptide laboratory research material. The label identifies CJC-1295 at 5 mg and Ipamorelin at 5 mg, and both amounts are carried consistently across the catalog page and structured product data.
Two-component peptide research material
CJC-1295 + Ipamorelin
5 mg + 5 mg · Lyophilized research material
$48
| Quantity | Price each | Discount |
|---|---|---|
| 1–4 vials | $48.00 | — |
| 5–9 vials | $44.64 | 7% off |
| 10+ vials | $40.80 | 15% off |
This page records both labeled components of the current DAAVY Research CJC-1295 + Ipamorelin listing together with its availability and analytical-document status.
- Labeled amount
- CJC-1295 5 mg + Ipamorelin 5 mg
- Testing
- Third-party testing complete
- COA
- COA7573
- Use restriction
- For Research Purposes Only
Research background
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), and Ipamorelin is a synthetic pentapeptide that acts as a selective ghrelin-receptor agonist. Published research has evaluated both compounds, individually and in combination, for their effects on growth hormone secretion in clinical and preclinical study settings. This catalog listing has not been evaluated for the purposes described in this research. DAAVY Research supplies this material only for legitimate laboratory, analytical, academic, or institutional research; it is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention.
Analytical documentation
Third-party COA7573 identifies the sample as CJC-1295 without DAC and Ipamorelin and records identity, component content, and overall purity testing by Bioviridians.
Research-use controls
This material is supplied only for legitimate laboratory, analytical, academic, or institutional research. It is not intended for human or veterinary use or consumption, diagnosis, treatment, or prevention.